Skip to main content
Kolon TissueGene, Inc. logo

Kolon TissueGene, Inc. — Investor Relations & Filings

Ticker · 950160 ISIN · KR8840120008 LEI · 5493000SYYLC88FUL781 KO Manufacturing
Open in API
Filings indexed 288 across all filing types
Latest filing 2020-08-28 Delisting Announcement
Country US United States of America
Listing KO 950160

About Kolon TissueGene, Inc.

https://www.tissuegene.com/

Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.

Recent filings

Filing Released Lang Actions
기타시장안내(상장폐지 관련)
Delisting Announcement Classification · 100% confidence The document is a regulatory notice from the Korea Exchange regarding Kolon TissueGene, specifically addressing delisting procedures due to audit opinion issues. It is a formal market announcement regarding the status of the company's listing, which falls under the category of regulatory filings or announcements related to listing status. Since it is a specific regulatory notice regarding delisting procedures rather than a general report, it fits best under RNS (Regulatory Filings) as the fallback for regulatory announcements.
2020-08-28 Korean
주권매매거래정지기간변경(상장폐지 사유 발생)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange regarding a change in the trading suspension period for Kolon TissueGene. It cites specific regulatory rules (KOSDAQ market listing regulations) and details the suspension timeline. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like delisting (it is a suspension update) or financial reports, it falls under the general regulatory filing category.
2020-08-28 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Kolon TissueGene, Inc. for the period of January 1, 2020, to June 30, 2020. It contains detailed financial statements, business descriptions, management analysis, and governance information, which are characteristic of an interim/quarterly financial report. It is not an announcement of a report, but the report itself. H1 2020
2020-08-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, special relationships, and the purpose of holding shares. This type of document is classified as a Major Shareholding Notification (MRQ) in the provided schema.
2020-08-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by insiders or major shareholders. It details the acquisition of shares by Kolon Life Science in Kolon TissueGene. This falls under the category of 'Director's Dealing' (DIRS) as it reports share transactions by a major shareholder/insider.
2020-08-19 Korean
기타시장안내(상장적격성 실질심사 관련 절차 안내)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange regarding Kolon TissueGene. It details the status of a listing eligibility review and ongoing delisting procedures due to embezzlement, breach of trust, and audit opinion disclaimer. Since it is a regulatory announcement regarding market status and listing procedures rather than a full legal proceeding report or a specific financial filing, it falls under the general regulatory filing category.
2020-07-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.